67027 Implant eye drug system
Also known as: intravitreal implant, drug delivery implant, Ozurdex, dexamethasone implant, sustained release implant
Implantation of drug delivery system into or near the eye for sustained release of therapeutic medication (intraocular implant for steroid, antibiotic, or anti-inflammatory agents).
Clinical Context
Used for chronic eye conditions requiring long-term treatment: diabetic macular edema, retinal vein occlusion, uveitis, macular degeneration; avoids repeated injections.
RVU Breakdown
| Work RVU | 11.33 |
| Practice Expense RVU | 9.17 |
| Malpractice RVU | 0.91 |
| Total RVU | 21.41 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.